The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Olmesartan /Amlodipine Mylan 40 mg/ 10 mg film coated tablets

40mg/10 milligram(s) Film-coated tablet

McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/185/003

Main Information

Trade NameOlmesartan /Amlodipine Mylan 40 mg/ 10 mg film coated tablets
Active SubstancesOlmesartan medoxomil
Amlodpine besilate
Strength40mg/10 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/185/003

Group Information

ATC CodeC09DB Angiotensin II antagonists and calcium channel blockers
C09DB02 olmesartan medoxomil and amlodipine


Licence Issued18/05/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back